Asthma 12 and over Flashcards
(12 cards)
What should be offered to people aged 12 and over with newly diagnosed asthma?
A low-dose ICS/formoterol combination inhaler to be used as needed (as-needed AIR therapy).
What form of budesonide/formoterol is currently licensed for as-needed use in mild asthma?
Only the dry powder inhaler formulation is licensed; other forms would be off-label.
What should be done if a person presents highly symptomatic or with a severe exacerbation?
Start low-dose MART alongside acute treatment (e.g., oral corticosteroids), then consider stepping down to as-needed AIR therapy when controlled.
When should moderate-dose MART be offered?
If asthma is not controlled on low-dose MART.
What should be done if asthma is not controlled on moderate-dose MART despite good adherence?
Check FeNO and blood eosinophils. If raised, refer to a specialist. If not, trial an LTRA or LAMA for 8–12 weeks.
What happens after an 8–12 week LTRA or LAMA trial?
If asthma is controlled: continue
If partial improvement: add the other agent
If no improvement: switch to the other agent
When should a referral to an asthma specialist be made?
If asthma is not controlled despite moderate-dose MART and LTRA and LAMA trials.
What should people currently using SABA only be switched to?
Low-dose ICS/formoterol as-needed AIR therapy
What should be considered for people not controlled on regular low-dose ICS + SABA or similar regimens?
Switch to low-dose MART.
What should be considered for people not controlled on regular moderate-dose ICS + SABA or similar regimens?
Switch to moderate-dose MART
What should be considered when changing to MART from a regimen with supplementary therapy?
Whether to continue or stop the supplementary therapy based on initial benefit
When should people on high-dose ICS be referred?
If asthma is not controlled on this regimen.
